Outpatient Treatment With Lisocabtagene Maraleucel In 3 Clinical Studies Of Relapsed/Refractory Large B-Cell Nhl, Including Second-Line Transplant Noneligible Patients: Transcend Nhl 001, Outreach, And Pilot
BONE MARROW TRANSPLANTATION（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要